Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
Generative AI and Copyright: Emerging Legal and Policy Questions for Africa’s Creative Industries
by Tebogo Sibidla, Director Generative artificial intelligence (AI) is rapidly becoming one of the most contested issues in copyright law [...]
Direct-to-Device Satellite Connectivity: Regulatory Implications for Africa’s Digital Future
by Tebogo Sibidla - Director and Nothando Madondo - Associate Direct-to-device (“D2D”) satellite connectivity is emerging as one of the [...]
Satellite Regulation in Africa: Aligning Global Frameworks with National Policy Priorities
by Tebogo Sibidla, Director In Africa, where satellite connectivity is increasingly relevant to digital infrastructure strategies, the central policy question [...]
Part 2: The “One-Shot” Pre-Merger Consultation in South Africa. Preparation, Risk, and the Question no-one is asking
by Ahmore Burger-Smidt, Director and Head of Regulatory Confidentiality and gun-jumping - the tension at the heart of the process [...]
Payments Revolution: what every PSP operating in South Africa needs to know right now
By Natalie Scott, Director and Head of Sustainability South Africa's payment landscape is undergoing its most significant transformation in decades. [...]
Part 1: The “One-Shot” Pre-Merger Consultation in South Africa. What it means for your Deal
by Ahmore Burger-Smidt, Director and Head of Regulatory A new procedural reality On 13 February 2026, the Competition Commission published [...]
